Researchers find blood test shows neurotoxic complications of CAR-T cell therapy
The treatment of various tumours has been transformed by cell-based immunotherapy, often known as CAR-T cell therapy
Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The treatment of various tumours has been transformed by cell-based immunotherapy, often known as CAR-T cell therapy
A potentially toxic immune response to the treatment limits its availability to major transplant hospitals.
After settling in rural New Mexico, a cancer patient had to move 750 miles east and live in a trailer to access CAR-T treatment at the MD Anderson Cancer Center.
The study only included six patients with relapsed/refractory lymphoma but suggests a synergistic effect with two therapies. The study was published as a preprint and has not yet been peer reviewed.
A real-time, label-free potency assay for immune-cell mediated killing of 30 cancer spheroids has been developed.